Zhongchao Inc. (ZCMD) is the 300th largest of 300 Healthcare IT companies by market capitalisation, at 29,577.45, behind SOBR Safe, Inc. at 372,393.34. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VEEV | Veeva Systems Inc | primary | T-27 | Vertical Software | TG-05 | 44.53 Bn | 44.00 | 12.88 | 37.29 Bn |
| 2 | WAY | Waystar Holding Corp. | primary | T-27 | Vertical Software | TG-05 | 4.81 Bn | 35.70 | 3.99 | 4.62 Bn |
| 3 | DOCS | Doximity, Inc. | primary | T-27 | Vertical Software | TG-05 | 4.74 Bn | 28.79 | 7.23 | 4.05 Bn |
| 4 | CCC | CCC Intelligent Solutions Holdings Inc. | primary | T-27 | Vertical Software | TG-05 | 4.41 Bn | 101.68 | 3.97 | 4.30 Bn |
| 5 | EVCM | EverCommerce Inc. | primary | T-27 | Vertical Software | TG-05 | 1.40 Bn | 41.19 | 2.34 | 1.27 Bn |
| 6 | SDGR | Schrodinger, Inc. | primary | T-27 | Vertical Software | TG-05 | 1.32 Bn | -27.62 | 5.09 | 0.90 Bn |
| 7 | CERT | Certara, Inc. | primary | T-27 | Vertical Software | TG-05 | 1.21 Bn | -17.92 | 2.96 | 1.03 Bn |
| 8 | GDRX | GoodRx Holdings, Inc. | primary | T-27 | Vertical Software | TG-05 | 1.18 Bn | 72.66 | 1.51 | 0.89 Bn |
| 9 | HSTM | Healthstream Inc | primary | T-27 | Vertical Software | TG-05 | 0.85 Bn | 40.26 | 2.66 | 0.79 Bn |
| 10 | PHR | Phreesia, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.68 Bn | 64.68 | 1.33 | 0.68 Bn |
| 11 | CTEV | Claritev Corp | primary | T-27 | Vertical Software | TG-05 | 0.65 Bn | -2.30 | 0.65 | 0.63 Bn |
| 12 | WEAV | Weave Communications, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.58 Bn | -28.29 | 2.27 | 0.54 Bn |
| 13 | SOPH | SOPHiA GENETICS SA | primary | T-27 | Vertical Software | TG-05 | 0.55 Bn | -15.11 | 6.43 | 0.45 Bn |
| 14 | NRC | Nrc Health | primary | T-27 | Vertical Software | TG-05 | 0.48 Bn | 80.88 | 3.40 | 0.47 Bn |
| 15 | SLP | Simulations Plus, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.37 Bn | 45.82 | 4.54 | 0.32 Bn |
| 16 | SPOK | Spok Holdings, Inc | primary | T-27 | Vertical Software | TG-05 | 0.22 Bn | 18.29 | 1.65 | 0.21 Bn |
| 17 | AMWL | American Well Corp | primary | T-27 | Vertical Software | TG-05 | 0.22 Bn | -4.21 | 1.00 | 0.04 Bn |
| 18 | BRRN | Bryn Inc. | primary | T-27 | Vertical Software | TG-05 | 0.16 Bn | -720.88 | — | 0.16 Bn |
| 19 | OPRX | OptimizeRx Corp | primary | T-27 | Vertical Software | TG-05 | 0.15 Bn | 32.13 | 1.50 | 0.12 Bn |
| 20 | HCAT | Health Catalyst, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.13 Bn | -0.47 | 0.43 | 0.02 Bn |
| 21 | DH | Definitive Healthcare Corp. | primary | T-27 | Vertical Software | TG-05 | 0.11 Bn | -0.55 | 0.48 | -0.03 Bn |
| 22 | CCLD | CareCloud, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.09 Bn | 32.06 | 0.74 | 0.08 Bn |
| 23 | RSSS | Research Solutions, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.07 Bn | 15.80 | 1.52 | 0.06 Bn |
| 24 | DRIO | DarioHealth Corp. | primary | T-27 | Vertical Software | TG-05 | 0.07 Bn | -1.86 | 3.22 | 0.05 Bn |
| 25 | ONMD | OneMedNet Corp | primary | T-27 | Vertical Software | TG-05 | 0.04 Bn | -4.61 | 26.96 | 0.04 Bn |
| 26 | VYND | Vynleads, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -27.04 | — | 0.01 Bn |
| 27 | HLYK | HealthLynked Corp | primary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -1.49 | 5.45 | 0.01 Bn |
| 28 | ACON | Aclarion, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -0.63 | 69.07 | 0.01 Bn |
| 29 | AMST | Amesite Inc. | primary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -1.71 | 14.85 | 0.01 Bn |
| 30 | DOGP | Dogecoin Cash, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.16 | 2.26 | 0.00 Bn |
| 31 | VSEE | Vsee Health, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.11 | 0.09 | 0.00 Bn |
| 32 | WORXD | SCWorx Corp. | primary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.19 | 0.15 | 0.00 Bn |
| 33 | SOBR | SOBR Safe, Inc. | primary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.04 | 1.05 | 0.00 Bn |
| 34 | ZCMD | Zhongchao Inc. | primary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.01 | 0.00 | -0.01 Bn |
| 35 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.08 Bn | 31.49 | 6.77 | 642.33 Bn |
| 36 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 453.04 Bn | 71.80 | 7.04 | 446.51 Bn |
| 37 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 370.87 Bn | 117.16 | 5.57 | 363.78 Bn |
| 38 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 359.38 Bn | 24.02 | 0.80 | 333.97 Bn |
| 39 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 305.29 Bn | 13.79 | 4.44 | 298.00 Bn |
| 40 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.38 Bn | -64.83 | 6.15 | 184.12 Bn |
| 41 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.10 Bn | 37.11 | 2.54 | 150.70 Bn |
| 42 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.36 Bn | 31.45 | 10.99 | 130.51 Bn |
| 43 | MCK | Mckesson Corp | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 105.79 Bn | 20.32 | 0.26 | 103.19 Bn |
| 44 | RELX | Relx Plc | secondary | T-23 | Business Applications | TG-03 | 64.63 Bn | 5.22 | 4.50 | 64.32 Bn |
| 45 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 53.95 Bn | 11.58 | 1.01 | 46.98 Bn |
| 46 | NTRA | Natera, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 47.13 Bn | -244.55 | 17.41 | 46.03 Bn |
| 47 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 45.00 Bn | -25.05 | — | 45.00 Bn |
| 48 | IQV | Iqvia Holdings Inc. | secondary | H-11 | Pharma Services | HG-03 | 44.06 Bn | 33.68 | 2.59 | 42.11 Bn |
| 49 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.34 Bn | 60.81 | 2.45 | 38.68 Bn |
| 50 | ONC | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 40.49 Bn | 60.96 | 6.61 | 35.39 Bn |
| 51 | ROP | Roper Technologies Inc | secondary | T-19 | Business Applications | TG-03 | 40.28 Bn | 16.33 | 4.86 | 39.92 Bn |
| 52 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.36 Bn | 29.19 | 3.19 | 32.91 Bn |
| 53 | RMD | Resmed Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.94 Bn | 21.82 | 5.83 | 31.47 Bn |
| 54 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.10 Bn | 15.21 | 1.46 | 29.22 Bn |
| 55 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.57 Bn | -31.36 | 24.23 | 26.41 Bn |
| 56 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.47 Bn | 15.75 | 4.38 | 20.94 Bn |
| 57 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.24 Bn | -16.96 | 2,310.98 | 25.93 Bn |
| 58 | GPN | Global Payments Inc | secondary | T-54 | Fintech | TG-09 | 24.60 Bn | -25.59 | 2.40 | 19.84 Bn |
| 59 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.81 Bn | 15.85 | 6.60 | 18.15 Bn |
| 60 | SSNC | SS&C Technologies Holdings Inc | secondary | T-20 | Business Applications | TG-03 | 19.62 Bn | 23.78 | 2.99 | 19.26 Bn |
| 61 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.39 Bn | -47.81 | 1.32 | 18.50 Bn |
| 62 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 16.02 Bn | 16.58 | 3.48 | 14.40 Bn |
| 63 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.81 Bn | 22.28 | 4.69 | 15.42 Bn |
| 64 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.60 Bn | 11.03 | 1.88 | 15.19 Bn |
| 65 | TU | Telus Corp | secondary | C-01 | Telecommunications | CG-01 | 14.98 Bn | -23.58 | 0.68 | 14.45 Bn |
| 66 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.69 Bn | 17.20 | 6.03 | 13.85 Bn |
| 67 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 14.53 Bn | 61.18 | 4.99 | 13.51 Bn |
| 68 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.44 Bn | 40.58 | 4.11 | 13.83 Bn |
| 69 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.07 Bn | 217.01 | 14.52 | 11.76 Bn |
| 70 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.76 Bn | 10.23 | 0.84 | 12.64 Bn |
| 71 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.32 Bn | -46.79 | 7.91 | 10.51 Bn |
| 72 | ALGN | Align Technology Inc | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 11.30 Bn | 27.42 | 2.73 | 10.20 Bn |
| 73 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.81 Bn | -69.64 | 13.92 | 10.49 Bn |
| 74 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.46 Bn | -66.34 | 17.06 | 10.34 Bn |
| 75 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.11 Bn | -54.84 | — | 10.11 Bn |
| 76 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.11 Bn | -13.09 | 149.40 | 8.94 Bn |
| 77 | HSIC | Henry Schein Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 10.05 Bn | 24.14 | 0.74 | 10.80 Bn |
| 78 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.82 Bn | -26.87 | — | 9.06 Bn |
| 79 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 80 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.72 Bn | -38.47 | 92.56 | 9.03 Bn |
| 81 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 82 | OSCR | Oscar Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 8.81 Bn | 17.69 | 0.58 | 0.26 Bn |
| 83 | TXG | 10x Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.16 Bn | -108.40 | 13.23 | 7.61 Bn |
| 84 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.72 Bn | 116.43 | 4.63 | 7.07 Bn |
| 85 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.62 Bn | -84.28 | — | 7.62 Bn |
| 86 | HNGE | Hinge Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 7.41 Bn | 68.00 | 10.30 | 7.03 Bn |
| 87 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 7.08 Bn | 67.46 | 7.16 | 6.29 Bn |
| 88 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.97 Bn | -734.96 | 5,007.81 | 6.97 Bn |
| 89 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.45 Bn | -39.59 | 1.21 | 6.14 Bn |
| 90 | NICE | NICE Ltd. | secondary | T-26 | Workplace Software | TG-04 | 6.38 Bn | 6.89 | 1.08 | 6.02 Bn |
| 91 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.15 Bn | -140.40 | 10.40 | 6.03 Bn |
| 92 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.12 Bn | 44.04 | 13.57 | 5.83 Bn |
| 93 | RDNT | RadNet, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 5.80 Bn | 298.26 | 2.55 | 5.37 Bn |
| 94 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.73 Bn | -209.27 | 30.74 | 5.41 Bn |
| 95 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.57 Bn | 25.85 | 1.79 | 5.53 Bn |
| 96 | EXLS | ExlService Holdings, Inc. | secondary | T-63 | Technology Services | TG-11 | 5.56 Bn | 22.34 | 2.48 | 5.27 Bn |
| 97 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.06 Bn | -17.55 | — | 5.06 Bn |
| 98 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.82 Bn | 12.64 | 4.24 | 3.87 Bn |
| 99 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.68 Bn | 48.50 | 3.46 | 4.46 Bn |
| 100 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.64 Bn | -23.51 | — | 4.64 Bn |
| 101 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.35 Bn | -46.65 | — | 4.35 Bn |
| 102 | HTFL | Heartflow, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 4.24 Bn | -174.15 | 20.90 | 3.87 Bn |
| 103 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.22 Bn | -11.92 | — | 4.22 Bn |
| 104 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.12 Bn | 11.71 | 3.10 | 3.90 Bn |
| 105 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.11 Bn | -46.17 | — | 4.11 Bn |
| 106 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.04 Bn | — | — | 3.75 Bn |
| 107 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.93 Bn | -83.93 | 6.48 | 3.48 Bn |
| 108 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 109 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.77 Bn | -8.13 | 32.18 | 3.06 Bn |
| 110 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 111 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.56 Bn | -8.16 | 987.61 | 3.56 Bn |
| 112 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.03 Bn | -11.21 | 593.06 | 2.51 Bn |
| 113 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.99 Bn | -12.08 | 419.65 | 2.99 Bn |
| 114 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.94 Bn | -15.57 | 6.55 | 2.24 Bn |
| 115 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -80.78 | — | 2.80 Bn |
| 116 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.71 Bn | -8.51 | 73.73 | 2.27 Bn |
| 117 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.67 Bn | 4.61 | 0.06 | -3.12 Bn |
| 118 | CDNA | CareDx, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 2.62 Bn | 23.59 | 5.72 | 2.25 Bn |
| 119 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.61 Bn | -21.89 | 2.00 | 2.52 Bn |
| 120 | PRVA | Privia Health Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.61 Bn | 77.08 | 1.11 | 2.25 Bn |
| 121 | WGS | GeneDx Holdings Corp. | secondary | H-17 | Healthcare Providers | HG-04 | 2.56 Bn | -24.02 | 5.64 | 2.43 Bn |
| 122 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -6.59 | 4.75 | 2.19 Bn |
| 123 | LIFE | Ethos Technologies Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 2.54 Bn | -20.77 | 4.49 | 2.37 Bn |
| 124 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.53 Bn | -29.70 | 3.21 | 2.16 Bn |
| 125 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.49 Bn | -6.84 | — | 2.49 Bn |
| 126 | HURN | Huron Consulting Group Inc. | secondary | I-26 | Business Services | IG-06 | 2.47 Bn | 21.78 | 1.76 | 2.44 Bn |
| 127 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | -64.08 | — | 2.46 Bn |
| 128 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | 13.72 | 2.56 | 1.65 Bn |
| 129 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | -2.25 | 0.23 | 1.58 Bn |
| 130 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.37 Bn | -4.03 | — | 2.10 Bn |
| 131 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -21.96 | 13.89 | 2.36 Bn |
| 132 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.26 Bn | -42.59 | — | 1.95 Bn |
| 133 | FLYW | Flywire Corp | secondary | T-54 | Fintech | TG-09 | 2.26 Bn | 66.71 | 3.16 | 1.96 Bn |
| 134 | CLOV | Clover Health Investments, Corp. /De | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.25 Bn | -121.62 | 0.91 | 2.02 Bn |
| 135 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | 6.66 | 6.86 | 1.69 Bn |
| 136 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.11 Bn | 1.84 | 0.08 | 1.41 Bn |
| 137 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -4.99 | 2,082.32 | 2.08 Bn |
| 138 | PGNY | Progyny, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.01 Bn | 25.80 | 1.53 | 1.77 Bn |
| 139 | INOD | Innodata Inc | secondary | T-63 | Technology Services | TG-11 | 1.91 Bn | 31.88 | 6.03 | 1.66 Bn |
| 140 | BFLY | Butterfly Network, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.75 Bn | -25.77 | 15.62 | 1.62 Bn |
| 141 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.70 Bn | 13.96 | 1.74 | 1.34 Bn |
| 142 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | -9.11 | 20.12 | 1.38 Bn |
| 143 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.65 Bn | 169.20 | 16.49 | 1.63 Bn |
| 144 | OMCL | Omnicell, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.57 Bn | 40.11 | 1.26 | 1.28 Bn |
| 145 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.98 | 3.01 | 0.97 Bn |
| 146 | ABSI | Absci Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | -11.47 | 969.66 | 1.31 Bn |
| 147 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | -3.37 | 2.10 | 1.22 Bn |
| 148 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -9.00 | — | 1.50 Bn |
| 149 | KMTS | Kestra Medical Technologies, Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.49 Bn | -10.51 | 15.68 | 1.13 Bn |
| 150 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -85.88 | 4.41 | 1.36 Bn |
| 151 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.44 Bn | -43.03 | 5.24 | 1.36 Bn |
| 152 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -24.58 | — | 1.42 Bn |
| 153 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.38 Bn | -21.69 | 1.33 | 0.93 Bn |
| 154 | AZTA | Azenta, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.37 Bn | -4.51 | 1.30 | 1.05 Bn |
| 155 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.37 Bn | 80.09 | 35.55 | 1.37 Bn |
| 156 | CLVT | Clarivate Plc | secondary | T-22 | Business Applications | TG-03 | 1.33 Bn | -3.98 | 0.55 | 1.11 Bn |
| 157 | AFYA | Afya Ltd | secondary | D-28 | Consumer Services | DG-09 | 1.33 Bn | 5.87 | 1.25 | 1.14 Bn |
| 158 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.22 Bn | -32.69 | 2.08 | 0.92 Bn |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | -27.82 | — | 1.00 Bn |
| 160 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.18 Bn | -4.95 | 15.26 | 1.18 Bn |
| 161 | TDOC | Teladoc Health, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 1.14 Bn | -6.41 | 0.46 | 0.37 Bn |
| 162 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.05 Bn | 71.04 | 1.41 | 0.80 Bn |
| 163 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | -72.45 | — | 0.95 Bn |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | -15.59 | 24.14 | 0.81 Bn |
| 165 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -48.72 | — | 0.97 Bn |
| 166 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.70 | — | 0.74 Bn |
| 167 | CBLL | Ceribell, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.94 Bn | -14.25 | 9.27 | 0.82 Bn |
| 168 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -5.50 | — | 0.94 Bn |
| 169 | IVA | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.92 Bn | 9.58 | 177.00 | 0.92 Bn |
| 170 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.86 Bn | -11.07 | 104.97 | 0.86 Bn |
| 171 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | 15.94 | 0.95 | 0.62 Bn |
| 172 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | -8.10 | 3.17 | 0.58 Bn |
| 173 | PAYS | Paysign, Inc. | secondary | T-54 | Fintech | TG-09 | 0.76 Bn | 47.64 | 7.55 | 0.58 Bn |
| 174 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | -7.12 | 8.48 | 0.61 Bn |
| 175 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 12.59 | 5.40 | 0.51 Bn |
| 176 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -37.38 | 6.09 | 0.70 Bn |
| 177 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | -8.53 | 12.39 | 0.57 Bn |
| 178 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | 5.25 | 1.75 | 0.40 Bn |
| 179 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -18.99 | — | 0.65 Bn |
| 180 | CCSI | Consensus Cloud Solutions, Inc. | secondary | T-26 | Workplace Software | TG-04 | 0.65 Bn | 6.86 | 1.83 | 0.55 Bn |
| 181 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -362,547.56 | — | 0.64 Bn |
| 182 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -12.60 | 16.37 | 0.58 Bn |
| 183 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 184 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -17.86 | 1.94 | 0.57 Bn |
| 185 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.57 Bn | 1,197.37 | 5.98 | 0.47 Bn |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -2.52 | 4.78 | 0.41 Bn |
| 187 | FLGT | Fulgent Genetics, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.54 Bn | -6.55 | 2.25 | 0.28 Bn |
| 188 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -16.03 | 326.79 | 0.40 Bn |
| 189 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -10.27 | 78.36 | 0.28 Bn |
| 190 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -5.66 | 32.21 | 0.32 Bn |
| 191 | EVH | Evolent Health, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.49 Bn | -0.95 | 0.23 | 0.35 Bn |
| 192 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.68 | 44.52 | 0.24 Bn |
| 193 | MTLS | Materialise Nv | secondary | T-20 | Business Applications | TG-03 | 0.44 Bn | 28.64 | 1.38 | 0.44 Bn |
| 194 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -6.67 | — | 0.38 Bn |
| 195 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -7.97 | 19.43 | 0.16 Bn |
| 196 | HBB | Hamilton Beach Brands Holding Co | secondary | D-06 | Household Durables | DG-02 | 0.42 Bn | 7.27 | 0.68 | 0.32 Bn |
| 197 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -87.02 | 11.23 | 0.41 Bn |
| 198 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.59 | 39.16 | 0.30 Bn |
| 199 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | — | — | 0.37 Bn |
| 200 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | -12.52 | 725.63 | 0.24 Bn |
| 201 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -1.19 | 1.52 | 0.16 Bn |
| 202 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -3.33 | — | 0.32 Bn |
| 203 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.81 | 0.41 | 0.18 Bn |
| 204 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -5.31 | — | 0.31 Bn |
| 205 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.24 | 7.43 | 0.27 Bn |
| 206 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.30 | — | 0.29 Bn |
| 207 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -37.91 | — | 0.29 Bn |
| 208 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | 0.03 | 0.01 | -10.78 Bn |
| 209 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.04 | — | 0.29 Bn |
| 210 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.82 | 1.20 | 0.11 Bn |
| 211 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | — | — | 0.08 Bn |
| 212 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | -1.16 | — | 0.23 Bn |
| 213 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.37 | 7.58 | 0.22 Bn |
| 214 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -7.36 | — | 0.22 Bn |
| 215 | SEER | Seer, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | -2.05 | 15.21 | 0.22 Bn |
| 216 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.11 | 3.17 | 0.19 Bn |
| 217 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -31.43 | — | 0.21 Bn |
| 218 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -7.55 | 15.49 | 0.17 Bn |
| 219 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.47 | 107.91 | 0.15 Bn |
| 220 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -35.91 | 8.18 | 0.19 Bn |
| 221 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -1.45 | 8.72 | 0.19 Bn |
| 222 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -46.69 | — | 0.18 Bn |
| 223 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.47 | — | 0.13 Bn |
| 224 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -3.70 | 2,035.87 | -0.02 Bn |
| 225 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -2.91 | — | 0.16 Bn |
| 226 | QSI | Quantum-Si Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -1.70 | 95.44 | 0.15 Bn |
| 227 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.43 | 114.21 | 0.15 Bn |
| 228 | BMEA | Biomea Fusion, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -2.60 | — | 0.15 Bn |
| 229 | STXS | Stereotaxis, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -5.99 | 4.35 | 0.12 Bn |
| 230 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.77 | — | 0.11 Bn |
| 231 | NTHI | Neonc Technologies Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.79 | — | 0.13 Bn |
| 232 | STEX | Streamex Corp. | secondary | T-58 | Fintech | TG-09 | 0.13 Bn | -0.26 | 751.34 | 0.11 Bn |
| 233 | PAVM | PAVmed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.12 Bn | -1.23 | 988.54 | 0.10 Bn |
| 234 | AARD | Aardvark Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -1.68 | — | 0.04 Bn |
| 235 | NAUT | Nautilus Biotechnology, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -3.59 | 602.64 | 0.11 Bn |
| 236 | CPIX | Cumberland Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.44 | 3.25 | 0.10 Bn |
| 237 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | 2.80 | — | 0.09 Bn |
| 238 | CGTX | Cognition Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -2.55 | — | 0.10 Bn |
| 239 | VRCA | Verrica Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -3.59 | 3.00 | 0.08 Bn |
| 240 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.35 | 1.32 | -0.06 Bn |
| 241 | RGC | Regencell Bioscience Holdings Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | — | — | 0.09 Bn |
| 242 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.76 | 1.66 | 0.06 Bn |
| 243 | TENX | Tenax Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.35 | — | 0.09 Bn |
| 244 | ZEPP | Zepp Health Corp | secondary | T-08 | Computer Hardware | TG-02 | 0.08 Bn | -3.11 | 0.29 | 0.01 Bn |
| 245 | MNOV | Medicinova Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -6.98 | 91.85 | 0.08 Bn |
| 246 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.08 Bn | -0.09 | 3.90 | 0.08 Bn |
| 247 | RTGN | RetinalGenix Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.08 Bn | — | — | 0.08 Bn |
| 248 | CSBR | Champions Oncology, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.07 Bn | -61.45 | 1.22 | 0.07 Bn |
| 249 | PLRX | Pliant Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.78 | — | 0.07 Bn |
| 250 | CING | Cingulate Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.11 | — | 0.07 Bn |
| 251 | PMVP | PMV Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.14 | — | -0.01 Bn |
| 252 | BOLD | Boundless Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.01 | — | 0.06 Bn |
| 253 | HIT | Health In Tech, Inc. | secondary | T-55 | Fintech | TG-09 | 0.06 Bn | -36.03 | 1.75 | 0.06 Bn |
| 254 | VERU | Veru Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 121.51 | — | 0.04 Bn |
| 255 | ANVS | Annovis Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.06 | — | 0.06 Bn |
| 256 | NNOX | Nano-X Imaging Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -0.68 | 3.98 | 0.01 Bn |
| 257 | GOSS | Gossamer Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -0.34 | 1.08 | 0.00 Bn |
| 258 | ZENA | ZenaTech, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 0.06 Bn | 11.21 | 3.93 | 0.05 Bn |
| 259 | KPTI | Karyopharm Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.26 | 0.35 | -0.01 Bn |
| 260 | MDAI | Spectral AI, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.05 Bn | -5.93 | 3.28 | 0.04 Bn |
| 261 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.93 | 3.86 | 0.05 Bn |
| 262 | CLNN | Clene Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.43 | 235.39 | 0.05 Bn |
| 263 | IXHL | Incannex Healthcare Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.83 | — | 0.04 Bn |
| 264 | SY | So-Young International Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.58 | 0.17 | -0.07 Bn |
| 265 | APRE | Aprea Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.39 | — | 0.04 Bn |
| 266 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.72 | 4.79 | 0.04 Bn |
| 267 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -6.19 | 0.38 | 0.03 Bn |
| 268 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.20 | -0.08 Bn |
| 269 | QTI | Qt Imaging Holdings, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.04 Bn | -1.92 | 1.38 | 0.03 Bn |
| 270 | ACTU | Actuate Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.70 | — | 0.04 Bn |
| 271 | GRCE | Grace Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.82 | — | 0.03 Bn |
| 272 | NSRX | Nasus Pharma Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 273 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.04 Bn |
| 274 | CPHI | China Pharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.43 | 8.49 | 0.03 Bn |
| 275 | UG | United Guardian Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.50 | 2.93 | 0.02 Bn |
| 276 | EHTH | eHealth, Inc. | secondary | H-16 | Healthcare Providers | HG-04 | 0.03 Bn | -1.20 | 0.06 | -0.07 Bn |
| 277 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.03 Bn | -1.29 | — | 0.02 Bn |
| 278 | YI | 111, Inc. | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 0.03 Bn | -2.46 | 0.02 | 0.11 Bn |
| 279 | CRVO | CervoMed Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.86 | 79.16 | 0.03 Bn |
| 280 | YARW | Yarrow Bioscience, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.24 | 51.63 | 0.00 Bn |
| 281 | TXMD | TherapeuticsMD, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -138.26 | 7.82 | 0.02 Bn |
| 282 | BYSI | BeyondSpring Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.02 | — | 0.03 Bn |
| 283 | ATOS | Atossa Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.74 | — | 0.03 Bn |
| 284 | NXPL | NextPlat Corp | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.51 | 0.51 | 0.01 Bn |
| 285 | LTRN | Lantern Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.55 | — | 0.02 Bn |
| 286 | AYTU | Aytu Biopharma, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.76 | 0.42 | 0.00 Bn |
| 287 | CRVW | CareView Communications Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -8.55 | 2.48 | 0.02 Bn |
| 288 | AIFF | Firefly Neuroscience, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -2.46 | 12.93 | 0.01 Bn |
| 289 | BFRI | Biofrontera Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.42 | 0.51 | 0.02 Bn |
| 290 | ALLR | Allarity Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.87 | 903.73 | 0.02 Bn |
| 291 | BTLN | Glimpse Group, Inc. | secondary | T-25 | Workplace Software | TG-04 | 0.02 Bn | -4.77 | 2.55 | 0.02 Bn |
| 292 | MIRA | Mira Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.54 | — | 0.01 Bn |
| 293 | TVRD | Tvardi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.68 | — | 0.02 Bn |
| 294 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.28 | 0.03 Bn |
| 295 | COSM | Cosmos Health Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.79 | 0.22 | 0.01 Bn |
| 296 | ANEB | Anebulo Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.78 | — | 0.02 Bn |
| 297 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.08 | — | 0.01 Bn |
| 298 | KPRX | Kiora Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.43 | — | 0.02 Bn |
| 299 | INTI | Inhibitor Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.72 | — | 0.02 Bn |
| 300 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.01 Bn | -2.05 | — | 0.02 Bn |